Moberg Pharma AB (publ) (STO: MOB)
Sweden
· Delayed Price · Currency is SEK 17.85
+0.42 (2.41%)
Nov 29, 2024, 5:29 PM CET
Moberg Pharma AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Revenue | 8.78 | - | 0.21 | - | 33.66 | 50.49 | Upgrade
|
| Revenue Growth (YoY) | - | - | - | - | -33.33% | 62.30% | Upgrade
|
| Cost of Revenue | 2.33 | - | - | - | - | - | Upgrade
|
| Gross Profit | 6.45 | - | 0.21 | - | 33.66 | 50.49 | Upgrade
|
| Selling, General & Admin | 29.62 | 24.86 | 21.07 | 18.51 | 22.1 | 24.14 | Upgrade
|
| Research & Development | 2.45 | 3.66 | 1.18 | 3.45 | 5.54 | 6.74 | Upgrade
|
| Other Operating Expenses | -0.24 | -0.61 | -1.52 | -2.23 | -3.8 | -6.82 | Upgrade
|
| Operating Expenses | 31.83 | 27.91 | 20.72 | 19.73 | 23.83 | 24.05 | Upgrade
|
| Operating Income | -25.38 | -27.91 | -20.52 | -19.73 | 9.83 | 26.44 | Upgrade
|
| Interest Expense | -0.23 | -0.26 | -0.07 | -0.13 | -1.02 | -1.03 | Upgrade
|
| Interest & Investment Income | 3.15 | 2.3 | 0.79 | - | 0.02 | 0.02 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.45 | 0.45 | 0.29 | - | 0.21 | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0.11 | -0.08 | - | Upgrade
|
| EBT Excluding Unusual Items | -22.01 | -25.42 | -19.51 | -19.97 | 8.96 | 25.43 | Upgrade
|
| Pretax Income | -22.01 | -25.42 | -19.51 | -19.97 | 8.96 | 25.43 | Upgrade
|
| Income Tax Expense | -3.76 | -4.33 | -3.8 | -3.75 | 2.15 | 5.4 | Upgrade
|
| Earnings From Continuing Operations | -18.25 | -21.09 | -15.71 | -16.22 | 6.81 | 20.03 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | 23.59 | -1.05 | - | Upgrade
|
| Net Income to Company | -18.25 | -21.09 | -15.71 | 7.37 | 5.76 | 20.03 | Upgrade
|
| Minority Interest in Earnings | - | - | - | 0.13 | 0.11 | - | Upgrade
|
| Net Income | -18.25 | -21.09 | -15.71 | 7.49 | 5.87 | 20.03 | Upgrade
|
| Net Income to Common | -18.25 | -21.09 | -15.71 | 7.49 | 5.87 | 20.03 | Upgrade
|
| Net Income Growth | - | - | - | 27.73% | -70.71% | -98.21% | Upgrade
|
| Shares Outstanding (Basic) | 33 | 16 | 8 | 4 | 2 | 2 | Upgrade
|
| Shares Outstanding (Diluted) | 33 | 16 | 8 | 4 | 2 | 2 | Upgrade
|
| Shares Change (YoY) | 192.51% | 109.19% | 76.29% | 127.45% | 0.34% | 5.79% | Upgrade
|
| EPS (Basic) | -0.55 | -1.33 | -2.07 | 1.74 | 3.12 | 10.75 | Upgrade
|
| EPS (Diluted) | -0.55 | -1.33 | -2.07 | 1.70 | 3.07 | 10.60 | Upgrade
|
| EPS Growth | - | - | - | -44.57% | -71.07% | -98.32% | Upgrade
|
| Free Cash Flow | -26.99 | -33.21 | -16.84 | -15.3 | -10.41 | 3.95 | Upgrade
|
| Free Cash Flow Per Share | -0.81 | -2.09 | -2.22 | -3.55 | -5.50 | 2.10 | Upgrade
|
| Gross Margin | 73.46% | - | 100.00% | - | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -288.95% | - | -9911.59% | - | 29.21% | 52.36% | Upgrade
|
| Profit Margin | -207.75% | - | -7589.37% | - | 17.43% | 39.66% | Upgrade
|
| Free Cash Flow Margin | -307.26% | - | -8136.23% | - | -30.93% | 7.83% | Upgrade
|
| EBITDA | -24.73 | -26.96 | -19.62 | -19.73 | 9.88 | 28.96 | Upgrade
|
| EBITDA Margin | -281.53% | - | - | - | 29.36% | 57.37% | Upgrade
|
| D&A For EBITDA | 0.65 | 0.95 | 0.9 | 0 | 0.05 | 2.53 | Upgrade
|
| EBIT | -25.38 | -27.91 | -20.52 | -19.73 | 9.83 | 26.44 | Upgrade
|
| EBIT Margin | -288.95% | - | - | - | 29.21% | 52.36% | Upgrade
|
| Effective Tax Rate | - | - | - | - | 23.96% | 21.25% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.